Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjana Urosevic

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Seminars in Cancer Biology|November 6, 2007
HLA-G in the skin--friend or foe?Mirjana Urosevic
Current Opinion in Investigational Drugs (London, England : 2000)|July 12, 2007
Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomasMirjana Urosevic
Cancer|March 20, 2002
Immunotherapy for nonmelanoma skin cancer: does it have a future?Mirjana Urosevic, Reinhard Dummer
Human Immunology|November 7, 2003
HLA-G in skin cancer: a wolf in sheep's clothing?Mirjana Urosevic, Reinhard Dummer
Seminars in Cancer Biology|January 8, 2004
HLA-G and IL-10 expression in human cancer--different stories with the same messageMirjana Urosevic, Reinhard Dummer
American Journal of Clinical Dermatology|January 25, 2005
Role of imiquimod in skin cancer treatmentMirjana Urosevic, Reinhard Dummer
Cancer Research|February 5, 2008
Human leukocyte antigen-G and cancer immunoeditingMirjana Urosevic, Reinhard Dummer
Archives of Dermatological Research|October 9, 2007
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimodMaja Wuest, Reinhard Dummer, Mirjana Urosevic
The Journal of Pathology|February 22, 2002
HLA-G and its KIR ligands in cancer--another enigma yet to be solved?Mirjana Urosevic, Andreas Trojan, Reinhard Dummer
Experimental Dermatology|April 25, 2006
Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?Reinhard Dummer, Antonio Cozzio, Mirjana Urosevic
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Seminars in Cancer Biology|November 6, 2007
HLA-G in the skin--friend or foe?Mirjana Urosevic
Current Opinion in Investigational Drugs (London, England : 2000)|July 12, 2007
Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomasMirjana Urosevic
Cancer|March 20, 2002
Immunotherapy for nonmelanoma skin cancer: does it have a future?Mirjana Urosevic, Reinhard Dummer
Human Immunology|November 7, 2003
HLA-G in skin cancer: a wolf in sheep's clothing?Mirjana Urosevic, Reinhard Dummer
Seminars in Cancer Biology|January 8, 2004
HLA-G and IL-10 expression in human cancer--different stories with the same messageMirjana Urosevic, Reinhard Dummer
American Journal of Clinical Dermatology|January 25, 2005
Role of imiquimod in skin cancer treatmentMirjana Urosevic, Reinhard Dummer
Cancer Research|February 5, 2008
Human leukocyte antigen-G and cancer immunoeditingMirjana Urosevic, Reinhard Dummer
Archives of Dermatological Research|October 9, 2007
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimodMaja Wuest, Reinhard Dummer, Mirjana Urosevic
The Journal of Pathology|February 22, 2002
HLA-G and its KIR ligands in cancer--another enigma yet to be solved?Mirjana Urosevic, Andreas Trojan, Reinhard Dummer
Experimental Dermatology|April 25, 2006
Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?Reinhard Dummer, Antonio Cozzio, Mirjana Urosevic
Pageof 6